Application 021436

Type
NDA
Sponsor
OTSUKA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ABILIFYARIPIPRAZOLETABLET;ORAL10MGYesYes
002ABILIFYARIPIPRAZOLETABLET;ORAL15MGYesNo
003ABILIFYARIPIPRAZOLETABLET;ORAL20MGYesNo
004ABILIFYARIPIPRAZOLETABLET;ORAL30MGYesNo
005ABILIFYARIPIPRAZOLETABLET;ORAL5MGYesYes
006ABILIFYARIPIPRAZOLETABLET;ORAL2MGYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
21695-002ABILIFYARIPIPRAZOLERebel Distributors Corp.NDACurrent
21695-003ABILIFYARIPIPRAZOLERebel Distributors Corp.NDACurrent
21695-004ABILIFYARIPIPRAZOLERebel Distributors Corp.NDACurrent
21695-005ABILIFYARIPIPRAZOLERebel Distributors Corp.NDACurrent
43353-848ABILIFYARIPIPRAZOLEAphena Pharma Solutions - Tennessee, LLCNDACurrent
43353-849ABILIFYARIPIPRAZOLEAphena Pharma Solutions - Tennessee, LLCNDACurrent
43353-850ABILIFYARIPIPRAZOLEAphena Pharma Solutions - Tennessee, LLCNDACurrent
52959-604ABILIFYARIPIPRAZOLEH.J. Harkins Company, Inc.NDACurrent
55289-251ABILIFYARIPIPRAZOLEPD-Rx Pharmaceuticals, Inc.NDACurrent
55289-251ABILIFYARIPIPRAZOLEPD-Rx Pharmaceuticals, Inc.NDACurrent
55289-251ABILIFYARIPIPRAZOLEPD-Rx Pharmaceuticals, Inc.NDACurrent
55289-251ABILIFYARIPIPRAZOLEPD-Rx Pharmaceuticals, Inc.NDACurrent
55289-251ABILIFYARIPIPRAZOLEPD-Rx Pharmaceuticals, Inc.NDACurrent
55289-251ABILIFYARIPIPRAZOLEPD-Rx Pharmaceuticals, InNDACurrent
59148-006ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-006ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-006ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-006ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-006ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-006ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-006ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-006ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-007ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-007ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-007ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-007ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-007ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-007ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-007ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-007ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-008ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-008ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-008ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-008ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-008ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-008ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-008ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-008ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-009ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-009ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-009ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-009ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-009ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-009ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-009ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-009ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-010ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-010ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-010ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-010ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-010ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-010ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-010ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-010ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-011ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-011ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-011ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-011ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-011ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-011ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-011ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
59148-011ABILIFYARIPIPRAZOLEOtsuka America Pharmaceutical, Inc.NDACurrent
63629-3387ABILIFYARIPIPRAZOLEBryant Ranch PrepackNDACurrent
63629-3387ABILIFYARIPIPRAZOLEBryant Ranch PrepackNDACurrent
64725-0006ABILIFYARIPIPRAZOLETYA PharmaceuticalsNDACurrent
64725-0007ABILIFYARIPIPRAZOLETYA PharmaceuticalsNDACurrent
64725-0009ABILIFYARIPIPRAZOLETYA PharmaceuticalsNDACurrent
64725-8000ABILIFYARIPIPRAZOLETYA PharmaceuticalsNDACurrent
68151-4461ABILIFYARIPIPRAZOLECarilion Materials ManagementNDACurrent
68151-4982ABILIFYARIPIPRAZOLECarilion Materials ManagementNDACurrent
68151-5121ABILIFYARIPIPRAZOLECarilion Materials ManagementNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
81133SUPPL 2025-02-07
81132SUPPL 2025-02-07
81025SUPPL 2025-02-05
81024SUPPL 2025-02-05
81023SUPPL 2025-02-05
72780SUPPL2022-12-05
72779SUPPL2022-12-05
72756SUPPL2022-12-01
61819SUPPL2020-02-06
61818SUPPL2020-02-06
61817SUPPL2020-02-06
61816SUPPL2020-02-06
61792SUPPL2020-02-06
61791SUPPL2020-02-06
59634SUPPL2019-08-08
59633SUPPL2019-08-08
59622SUPPL2019-08-08
47424SUPPL2017-03-02
47330SUPPL2017-02-24
45787SUPPL2016-11-02
45238SUPPL2016-08-18
45086SUPPL2016-08-18
21657SUPPL2016-07-28
21656SUPPL2016-04-20
15466SUPPL2016-01-22
27780SUPPL2016-01-20
36925SUPPL2014-12-15
27779SUPPL2014-12-15
27777SUPPL2014-07-11
42164SUPPL2014-06-16
15464SUPPL2014-06-10
15465SUPPL2013-08-09
21654SUPPL2013-08-06
27778SUPPL2013-08-05
21653SUPPL2013-05-10
42160SUPPL2012-03-14
27776SUPPL2012-02-27
36924SUPPL2012-02-24
42163SUPPL2012-01-27
42162SUPPL2012-01-27
42161SUPPL2012-01-27
44122ORIG2011-12-22
5371SUPPL2011-03-08
15463SUPPL2011-03-07
36921SUPPL2011-02-24
5369SUPPL2011-02-18
5370SUPPL2010-12-07
36923SUPPL2010-12-03
27775SUPPL2010-12-03
36922SUPPL2010-12-02
5368SUPPL2009-11-27
15462SUPPL2009-11-23
24197SUPPL2009-08-20
21655SUPPL2009-08-20
27774SUPPL2009-07-24
36920SUPPL2009-07-23
15461SUPPL2008-08-26
5367SUPPL2008-08-19
24200SUPPL2008-07-17
24199SUPPL2008-07-17
24198SUPPL2008-07-17
27773SUPPL2008-05-14
27772SUPPL2008-05-14
5364SUPPL2008-05-14
5366SUPPL2008-03-07
5365SUPPL2008-02-29
15460SUPPL2008-02-28
27771SUPPL2007-11-19
15459SUPPL2007-11-19
27770SUPPL2007-11-08
36919SUPPL2007-11-07
5363SUPPL2007-10-04
36918SUPPL2007-09-26
42159SUPPL2007-09-24
21652SUPPL2007-09-24
36916SUPPL2006-10-23
27769SUPPL2006-10-23
36917SUPPL2006-09-20
5362SUPPL2006-09-20
36915SUPPL2006-02-22
27768SUPPL2006-02-22
36914SUPPL2005-06-23
27766SUPPL2005-06-23
27767SUPPL2005-03-03
27765SUPPL2005-03-03
15458SUPPL2005-03-03
15456SUPPL2005-03-03
27764SUPPL2004-10-04
15455SUPPL2004-10-04
15457SUPPL2004-05-03
5361SUPPL2004-04-20
15454SUPPL2003-09-09
5360SUPPL2003-09-09
42158ORIG2003-03-07
51237SUPPL2003-02-11
51236SUPPL2003-02-11
36913ORIG2002-11-15
27763ORIG2002-11-15
63504ORIG1900-01-01
63502SUPPL1900-01-01